Magnetic resonance imaging in patients with cardiomyopathies: When and why

Herz

Volumn 25, Issue 4, 2000, Pages 384-391

  Schulz Menger, Jeanette ^a   Friedrich, Matthias G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cardiomyopathy; Magnetic resonance imaging

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART DILATATION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART MUSCLE METABOLISM; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; RADIOISOTOPE VENTRICULOGRAPHY; REPRODUCIBILITY; RESTRICTIVE CARDIOMYOPATHY; SAFETY;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS;

EID: 0033911228     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000590050030     Document Type: Article

References (60)

1. Arrive L, Assayag P, Russ G, et al. MRI and cine MRI of asymmetric septal hypertrophic cardiomyopathy. J Comput Assist Tomogr 1994;18:376-82.
2. Benjelloun H, Cranney G, Kirk K, et al. Interstudy reproducibilty of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol 1991;67:1413-20.
3. Bottini P, Carr A, Prisant L, et al. Magnetic resosance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens 1995;8:221-8.
4. Chandra M, Silvermann M, Oshinski J, et al. Diagnosis of cardiac sarcoidosis aided by MRI. Chest 1996;110:562-5.
5. Cheitlin M. ACC/AHA guidelines for the clinical application of echocardiography. Circulation 1997;95:1686-744.
6. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 1999;72:258-64.
7. Doherty M, Kumar S, Nicholson A, et al. Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment. Respir Med 1998;92:697-9.
8. Doherty NE, Fujita N, Caputo GR, et al. Measurement of right ventricular mass in normal and dilated cardiomyopathic ventricles using cine magnetic resonance imaging. Am J Cardiol 1992;69:1223-8.
9. Fattori R, Rocchi G, Celletti F, et al. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998; 136:824-30.
10. Flora G, Sharma O. Myocardial sarcoidosis: a review. Sarcoidosis 1989;6:97-106.
11. Fontaine G, Fontaliran F, Hebert JL, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999;50:17-35.
12. Friedrich M, Strohm O, Osterziel K, et al. Growth hormone therapy in dilated cardiomyopathy monitored with MRI. MAGMA 1998;6:152-4.
13. Friedrich M, Strohm O, Schulz-Menger J, Marciniak H, Luft F, Dietz R. Noninvasive diagnosis of acute myocarditis by contrast enhanced magnetic resonance imaging. Proc ISMRM 6th Annual Meeting, Sydney, 1998:912.
14. Friedrich M, Strohm O, Schulz-Menger J, et al. Response to the author. Circulation 1999;99:458-9.
15. Friedrich MG, Strohm O, Schulz Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
16. Gagliardi M, Poletta B, Di Renzi P. MRI for the diagnosis and follow up of myocarditis (letter). Circulation 1999;99:458-9.
17. Gardin J, Dabestani A, Glasgow G, et al. Echocardiographic and Doppler flow observations in obstructed and non-obstructed hypertrophic cardiomyopathy. Am J Cardiol 1985;56:614-21.
18. Germain P, Roul G, Kastler B, et al. Inter-study variability in left ventricular mass measurement. Comparison between M-mode echocardiography and MRI. Eur Heart J 1992;13:1011-9.
19. Higgins C, Byrd B, Stark D. Magnetic resonance imaging of hypertrophic cardiomyopathy. Am J Cardiol 1985;1985:1121-6.
20. Jung W, Sieverding L, Breuer J, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97:2536-42.
21. Kawada N, Sakuma H, Yamakado T, et al. Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects. Radiology 1999;211:129-35.
22. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 1998;97:461-6.
23. Kyle R, Spittell P, Gertz M, et al. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395-400.
24. Maier S, Fischer S, McKinnon G, et al. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging. Circulation 1992;86:1919-28.
25. Masui T, Finck S, Higgings C. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with magnetic resonance imaging. Radiology 1992;182:369-72.
26. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
27. Mehta A, Mehta M, Jain A. Constrictive pericarditis. Clin Cardiol 1999;22:334-44.
28. Missouris CG, Forbat SM, Singer DR, et al. Echocardiography over-estimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 1996;14:1005-10.
29. Myers BH, Spodick DH. Constrictive pericarditis: Clinical and pathophysiologic characteristics. Am Heart J 1999;138:219-32.
30. Nakatani S, White RD, Powell KA, et al. Dynamic magnetic resonance imaging assessment of the effect of ventricular wall curvature on regional function in hypertrophic cardiomyopathy. Am J Cardiol 1996;77:618-22.
31. Neubauer S, Horn M, Cramer M, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190-6.
32. Neubauer S, Revel D, de Roos A, et al. The clinical role of magnetic resonance in cardiovascular disease - Task force of the European Society of Cardiology, in Collaboration with the Association of European Paediatric Cardiologists. Eur Heart J 1198,19:19-39
33. Osterziel K, Strohm O, Schuler J, et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone inpatients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998;351:1233-7.
34. Otake S, Banno T, Ohba S, et al. Muscular sarcoidosis: findings at MR-imaging. Radiology 1990;176:1227-33.
35. Otterstad J, Froeland E, Jon Sutton M, et al. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function [see comments]. Eur Heart J 1997;18:507-13.
36. Park JH, Kim YM. MR imaging of cardiomyopathy. Magn Reson lmag Clin N Am 1996;4:269-86.
37. Park JH, Kim YM, Chung JW, Park YB, Han JK, Han MC. MR imaging of hypertrophic cardiomyopathy. Radiology 1992;185:441-6.
38. Pattynama P, Lamb H, van der Velde E, et al. Reproducibility of MRI-derived measurements of right ventricular volumes and myocardial mass. Magn Reson Imag 1995;13:53-63.
39. Perry A, Vuitch F. Causes of death in patients with sarcoidosis. A morphological study of 38 autopsies with clinicopathological correlations. Arch Pathol Lab Med 1996;119:167-72.
40. Pons Llado G, Carreras F, Borras X, et al. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 1997;79:1651-6.
41. Posma JL, Blanksma PK, van der Wall EE, et al. Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. Am Heart J 1996;132:1020-7.
42. Richardson P, McKenna W. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
43. Rominger MB, Bachmann GF, Geuer M, et al. [Comparison of left and right ventricular ejection and filling parameters of the heart using cine-MRI with breath holding technique. Clinical study of 42 patients with cardiomyopathy and coronary heart disease]. Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;170:534-41.
44. Sardanelli F, Molinari G, Petillo A, et al. MRI in hypertrophic cardiomyopathy: a morphofunctional study. J Comput Assist Tomogr 1993;17:862-72.
45. Schulz-Menger J, Strohm O, Waigand J, et al. Magnetic resonance imaging accurately detects delayed improvement in left ventricular outflow tract following septal artery embolisation in hypertrophic obtructive cardiomyopathy. Circulation 1997;96:1054.abstract.
46. Sechtem U, Tscholakoff D, Higgings C. MRI of the abnormal pericardium. Am J Roentgenol 1986;147:239-44.
47. Seltzer S, Mark A, Atlas S. CNS-sarcoidosis: evaluation with contrast-enhanced MR imaging. AJNR 1991;12:1227-33.
48. Semelka R, Tomei E, Wagner S. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphological abnormal left ventricle. Am Heart J 1990;1990:1367-73.
49. Siegelmann E, Mitchell D, Semelka R. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1997;199:13-22.
50. Soler R, Rodriguez E, Marini M. Left ventricular mass in hypertrophic cardiomyopathy: assessment by three-dimensional and geometric MR methods. J Comput Assist Tomogr 1999;23:577-82.
51. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy [see comments]. N Engl J Med 1997; 336:775-85.
52. Stuber M, Nagel E, Fischer SE, et al. Quantification of the local heartwall motion by magnetic resonance myocardial tagging. Comput Med Imag Graph 1998;22:217-28.
53. Stuber M, Scheidegger M, Fischer S, et al. Alteration in the local myocardial motion pattern in patients suffering from pressure overload due to aortic stenosis. Circulation 2000;101:1764-6.
54. Suzuki J, Shimamato R, Nishikawa J, et al. Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol 1999;33:146-51.
55. Tsukihashi H, Ishibashi Y, Shimada T, et al. [Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy]. J Cardiol 1994;24:185-91.
56. van Rossum A, Visser F, Hofman M, et al. Global left ventricular perfusion: noninvasive measurement with cine MR imaging and phase velocity mapping of coronary venous outflow. Radiology 1992;182:685-91.
57. van Royen N, Jaffe C, Krumholz H, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide imaging for measuring left ventricular ejection fraction. Am J Cardiol 1996;77:843-50.
58. Waxmann S, Eustace S, Haernell G. Myocardial involvment in primary hemochromatosis demonstrated by magnetic resonance imaging. Am Heart J 1994;128:1047-9.
59. White RD, Obuchowski NA, Gunawardena S, et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. Am J Card Imag 1996;10:1-13.
60. Wichter T, Borggrefe M, Breithardt G. [Arrhythmogenic right ventricular cardiomyopathy. Etiology, diagnosis and therapy]. Med Klin 1998;93:268-77.